STAT3 and head and neck squamous cell carcinoma: Additionally, studies have reported that AG490, a JAK2 inhibitor, suppresses angiogenesis and reduces MDSCs within the HNSCC TME by inhibiting the JAK2/STAT3 pathway [27, 278].